TATRAMED SOFTWARE SRO

Their core work

TATRAMED is a Slovak software SME that develops image analysis and computational tools for biomedical research, particularly for processing and interpreting microscopy and imaging data from biological experiments. Their work sits at the intersection of software engineering and life sciences — they build the tools that researchers use to track cells, model biological processes, and extract quantitative insights from complex imaging data. In H2020, they contributed as an industry partner inside large Marie Curie training networks, bringing practical software development capacity to consortia otherwise dominated by academic institutions. Their involvement in both a developmental biology imaging network and an inflammation research network suggests they serve as a versatile computational partner across biomedical domains.

What they specialise in

How they've shifted over time

In their first project (ImageInLife, 2017-2021), TATRAMED worked on general multilevel bioimaging and developmental biology modelling — broad foundational work with no keywords specific to disease or immune function. By their second project (INFLANET, 2021-2025), the focus sharpened considerably toward inflammation biology: neutrophils, macrophages, intravital imaging, molecular sensors, and anti-inflammatory strategies. This shift suggests TATRAMED is moving from general-purpose bioimaging tools toward domain-specific software for immunology and inflammation research.

TATRAMED appears to be specialising toward immunology and inflammation as a software niche, making them an increasingly targeted fit for consortia working on immune cell dynamics, intravital microscopy, or preclinical inflammation models.

How they like to work

TATRAMED has exclusively joined projects as a participant, never as coordinator — a pattern consistent with an SME that contributes a specific technical capability rather than driving scientific agendas. Both projects were large MSCA Innovative Training Networks with many partners, which means TATRAMED is comfortable operating inside complex multi-institutional consortia. Their 24 unique partners across just 2 projects confirms they work in wide, diverse networks rather than repeatedly with the same small group.

TATRAMED has built connections with 24 distinct organisations across 8 countries, an unusually broad network for just two projects — a direct result of participating in large MSCA training networks that span multiple European institutions. Their geographic reach is European, with no indication of partnerships outside EU/associated countries.

What sets them apart

TATRAMED occupies a rare niche as a private software company embedded in biomedical research training networks — most such networks are built entirely from universities and research institutes. This gives them direct access to cutting-edge biomedical imaging research while maintaining a commercial orientation that pure academic partners lack. For consortium builders, they offer a credible industry presence in health research proposals without requiring large-scale manufacturing or clinical infrastructure.

Highlights from their portfolio

• INFLANET
  Their most recent and best-funded project (EUR 233,247), focused on inflammation biology from molecular to clinical levels — representing their most domain-specific and commercially relevant engagement to date.
• ImageInLife
  Their entry into H2020, establishing credentials in multilevel bioimaging and vertebrate development modelling within a large European training network.